Pharmacists in Kennebunk, ME Accepting Medicare

11 Pharmacists found. Showing 1 - 11

Jennifer Lindsley Stevens, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11 Carriedale Ln, Kennebunk, ME 04043 Phone: 207-985-3587

Katherine Lynn Nappi Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 37 Portland Rd, Kennebunk, ME 04043 Phone: 207-985-7144

Ashley J Moulton, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 37 Portland Rd, Kennebunk, ME 04043 Phone: 207-985-7144

Kristen Hope Beaulieu, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 37 Portland Rd, Kennebunk, ME 04043 Phone: 207-985-7144

Elizabeth Bennett Pritchard Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 65 Portland Rd, Kennebunk, ME 04043 Phone: 207-985-9177

Dr. Faisal S Abdillahi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 65 Portland Rd Ste 9, Kennebunk, ME 04043 Phone: 207-985-9177

Bruce C Church, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 65 Portland Rd, Kennebunk, ME 04043 Phone: 207-985-9177    Fax: 207-985-9209

Lawrence Ford Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 37 Portland Rd, Kennebunk, ME 04043 Phone: 207-985-7144

Dr. John Tederous Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 48 Portland Rd, Kennebunk, ME 04043 Phone: 207-467-8299

Madison Russell Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 48 Portland Rd, Kennebunk, ME 04043 Phone: 207-467-8299

Gillian Purcell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 65 Portland Rd Ste 9, Kennebunk, ME 04043 Phone: 207-985-9177

News Archive

"Cat's claw" extract inhibits replication of SARS-CoV-2 in vitro

Researchers in Columbia and Peru have shown that Uncaria tomentosa – a woody vine native to South America known of as "Cat's claw" – exerts in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).

Stem cell transplantation improves outcomes in children with rare form of chronic blood cancer

Researchers in the Division of Hematology, Oncology and Blood & Marrow Transplantation at Children's Hospital Los Angeles have shown greatly improved outcomes in using stem cell transplantation to treat patients with a serious but very rare form of chronic blood cancer called juvenile myelomonocytic leukemia (JMML).

Gates Foundation grant to promote effective use of new cholera vaccine

The Johns Hopkins Bloomberg School of Public Health was awarded a four-year, $5 million grant from the Bill & Melinda Gates Foundation to promote the effective use of oral cholera vaccine around the world. The Delivering Oral Vaccine Effectively (DOVE) program will provide relief agencies and governments with technical assistance on how to use oral cholera vaccine, evaluate current vaccine-use practices and develop new field surveillance methods for monitoring and controlling outbreaks of the disease.

Molecular profiling can accurately predict survival in colon cancer patients

Barcelona, Spain: Researchers in The Netherlands have developed a method of accurately predicting which patients with colon cancer are most likely to have their disease recur after surgery and who would, therefore, be likely to benefit from additional chemotherapy.

Read more Medical News

› Verified 9 days ago